Talk track

Key Messages

  • STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device has a unique anchor design and is the only barbed suture appropriate for high-tension areas, such as the fascia.1,2
  • The strength is a result of an intact core and geometrically patterned anchors which deliver strength and security with every pass without the need to tie knots.1,3-4
  • STRATAFIX™ Symmetric PDS™ Plus is 39% stronger than Coated VICRYL™ sutures with an interrupted technique, and 25% stronger than PDS™ Plus Antibacterial (polydioxanone) Suture.1*
  • STRATAFIX™ Symmetric PDS™ Plus 15% greater tissue holding strength than V-Loc(TM) 180 device1 and provides 6 weeks of tissue strength compared with V-Loc’s(TM) 3 weeks.4-7
  • Incorporates antibacterial technology with triclosan coating, which has been shown to inhibit bacterial colonization of the suture for 11 days or more​.8
  • Aligns with recommendations by the CDC, ACS/Surgical Infection Society, and NICE guidelines, which all advise that triclosan-coated sutures should be used to reduce the risk of SSIs.9-13*†
  • A meta-analysis of 21 randomized controlled trials showed a 28% reduction in SSI risk with the use of triclosan-coated sutures​.14‡§
  • Eliminates the need for knot tying, which not only Closure with STRATAFIX™ Knotless Tissue Control Device is more efficient than continuous closure with traditional sutures since there is no need to tie knots or have an assistant follow the suture.15,16

Detailed Talk Track

I can understand that when you encounter a suture breaking while closing the fascia this can be frustrating. Choosing a suture that can withstand high-tension areas like the fascia is critical. I’d like to introduce you to a solution designed to address these exact challenges—STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device. With a unique anchor design, STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device is the only barbed suture appropriate for high-tension areas, such as the fascia.1,2 The strength of the STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device is a result of an intact core and geometrically patterned anchors which deliver strength and security with every pass without the need to tie knots.1,3-4 Bench top testing has shown that the STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device is 39% stronger than Coated VICRYL(TM) sutures with an interrupted technique, and 25% stronger than PDS™ Plus Antibacterial (polydioxanone) Suture.1* Another study showed that STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device had 15% greater tissue holding strength than V-Loc(TM) 180 device1 and provides 6 weeks of tissue strength compared with V-Loc’s(TM) 3 weeks.4-7 If reducing SSIs is mentioned as important STRATAFIX™ Symmetric PDS™ Plus incorporates antibacterial technology with triclosan coating, which has been shown to inhibit bacterial colonization of the suture for 11 days or more​.8 Using STRATAFIX™ Symmetric PDS™ Plus sutures aligns with recommendations by the CDC, ACS/Surgical Infection Society, and NICE guidelines, which all advise that triclosan-coated sutures should be used to reduce the risk of SSIs.9-13*† In fact, a meta-analysis of 21 randomized controlled trials showed a 28% reduction in SSI risk with the use of triclosan-coated sutures​.14‡§ If efficiency is mentioned as important STRATAFIX™ Symmetric PDS™ Plus eliminates the need for knot tying, which not only Closure with STRATAFIX™ Knotless Tissue Control Device is more efficient than continuous closure with traditional sutures since there is no need to tie knots or have an assistant follow the suture.15,16 This is particularly beneficial in robotic surgeries where dexterity can be limited by instrumentation​​. This can translate into smoother workflows and reduced fatigue during lengthy robotic cases.

References

*CDC, WHO, ACS/SIS, NICE, and KRINKO guidelines on reducing the risk of surgical site infections are general to triclosan-coated sutures and are not specific to any one brand.

†All triclosan-coated sutures in these RCTs were Ethicon Plus Antibacterial Sutures (MONOCRYL™ Plus, VICRYL™ Plus, and PDS™ Plus).

‡In a meta-analysis of 21 RCTs, 6462 patients, 95% CI: (14, 40%), P<0.001

§All triclosan-coated sutures in these RCTs were Ethicon Plus Antibacterial Sutures (MONOCRYL™ Plus, VICRYL™ Plus, and PDS™ Plus)

1. 100326296: Time Zero Tissue Holding – Competitive Claims Comparisons for STRATAFIX Knotless Tissue Control Devices vs Various Products. 2015. Ethicon, Inc.

2. V-Loc 180 Absorbable Wound Closure Device. Instructions for Use. Medtronic.

3. AST-2013-0056 Performance Testing of STRATAFIX Symmetric PDSSize2-0 suture device for

Tissue Holding Strength with Multiple Incision Defects to Measure Gapping. Ethicon, Inc.

4. STRATAFIX™ Symmetric PDS™ Plus Knotless Tissue Control Device, Instructions for Use. Ethicon, Inc.

5. STRATAFIX™ Spiral PDS™ Plus Knotless Tissue Control Device, Instructions for Use. Ethicon, Inc.

6. STRATAFIX™ Spiral PDO Knotless Tissue Control Device, Instructions for Use. Ethicon, Inc.

7. Medtronic, V-Loc™ 180 Absorbable Wound Closure Device Instructions for Use.

8. Bhende S, Burkley D, Nawrocki J. In vivo and in vitro antibacterial efficacy of absorbable barbed poydioxanone monofilament tissue control device with triclosan. Surg Infect 2018; Volume 19 (4):430-437.

9. Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection. JAMA Surg. 2017;152(8):784_791.

doi:10.1001_jamasurg. 2017.0904.

10. World Health Organization. Global Guidelines for the Prevention of Surgical Site Infection. https:__apps.who.int_iris_bitstream_handle_10665_250680_9789241549882-eng.pdf?sequence=8. Published November 2016. Accessed August 24, 2023

11. Ban KA, Minei JP, Laronga C, et al. American College of Surgeons and Surgical Infection Society:

Surgical Site Infection Guidelines, 2016 Update. J Am Coll Surg. 2016;224(1):59_74.

12. National Institute for Health and Care Excellence (NICE) Guideline. Surgical site infections: prevention and treatment. NICE website. https:__www.nice.org.uk_guidance_ng125_chapter_Recommendations#closuremethods. Accessed August 24, 2023.

13. Prevention of postoperative wound infections. Recommendation of the Committee for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute. Bundesgesundheitsbl. 2018; 61(4):448_473

14. de Jonge SW, Atema JJ, Solomkin JS, Boermeester MA. Meta-analysis and trial sequential analysis of triclosan-coated sutures for the prevention of surgical site infection. Brit J Surg. 2017;ePub-DOI: 10.1002_bjs.10445.

15. Einarsson JI, Chavan NR, Suzuki Y, Jonsdottir G, Vellinga TT, Greenberg JA. Use of bidirectional barbed suture in laparoscopic myomectomy: evaluation of perioperative outcomes, safety, and efficacy. J Minim Invasive Gynecol. 2011;18(1):92-95.

16. Warner JP, Gutowski KA. Abdominoplasty with progressive tension closure using a barbed suture technique. Aesthet Surg J. 2009;29(3):221-225.

CONFIDENTIAL. FOR INTERNAL USE ONLY. NOT FOR USE WITH ANY CUSTOMER OR FOR EXTERNAL DISTRIBUTION.

Close

Click for assets
STRATAFIX™ Symmetric resources